Appeals court rules the constitution guarantees no right to clean water
A dissenting judge compared the Jackson, Mississippi water crisis to Flint's
Trump says he is in ‘deciding mode’ on destroying Iran
The Pentagon's own death count is undercounting US troops killed in the seven-month war, the Washington Post has reported.
NAACP sues Trump administration over armed agents at the polls
The suit cites a fatal Minneapolis shooting by federal agents as evidence of the fear such deployments can create.
Secret Pfizer and Lilly contracts favor drugmakers over patients, records show
The deals let companies raise prices overseas while carving blockbuster obesity drugs out of required discounts.
Private jets use 7 percent of airspace but pay under 0.6 percent of aviation...
The Institute for Policy Studies also counts more than $1.13 billion in airport grants that may mainly benefit private jets, as a provision in the ALERT Act draws opposition over state tax enforcement.
Hundreds of Las Vegas Culinary Union members are protesting their own union over health...
Dissidents say the new clinic-based plan limits their choice of doctors, while leaders describe a small group spreading misinformation about a plan with no premiums, copays or deductibles.
Labor department sues Oklahoma nonprofit coffee chain over wages and tips
The lawsuit covers more than 320 employees, some with disabilities, going back to 2023
SEC votes to propose scrapping rule that lets shareholders force a vote
Investor advocates call the move a threat to eight decades of shareholder oversight
Flood-damaged Nepal wants help from the global climate Loss and Damage Fund – but...
Getting Loss and Damage Fund money would be worth a lot more than the $20 million Nepal is asking for. The foreign minister calls it a demand for justice and ‘legal and moral liability.
The Drugs and Devices Have Been on the Market for Years. But FDA-Ordered Studies...
To get drugs and devices out faster, the FDA lets companies conduct studies of safety or efficacy after the products are approved. In many cases, such “postmarket” studies are behind schedule or overdue, records show.